Doctored Images, Fake Data, & Plagiarism: Scandals Rock Alzheimer’s & Cancer Research. Research Director Falsifying Vaccine Data Retains Post

August 4, 2022

In another update, Southwest National Primate Research Center (SNPRC) is allowing one if its directors who published fraudulent research on tuberculosis vaccines to retain his post, according to Science.org

“[Deepak Kaushal] engaged in research misconduct by intentionally, knowingly, and/or recklessly falsifying and fabricating the experimental methodology to demonstrate results obtained under different experimental conditions,” according to ORI findings published in the Federal Register on Monday.

The ORI’s investigation found that Kaushal “engaged in research misconduct” involving one published study and two grant applications under at least eight U.S. government grants from the Institute of Allergy and Infectious Diseases (NIAID) and National Institutes of Health (NIH).   

________________________

**UPDATE Aug. 2022**

http://    Approx. 20 Min

Aug. 3, 2022

Another Major Blow to Science, Trust, the FDA, and Peer-Review

By Chris Martenson

Go here if Youtube censors the video.

And here for another video on “Bad Science: Breaking Our Public Trust”

https://www.medpagetoday.com/special-reports/features/99918?

Doctored Images in Alzheimer’s Research?

By Sophie Putka

July 27, 2022

Excerpts:

An investigation by Science Magazine tells how Matthew Schrag, MD, PhD, neuroscientist and physician at Vanderbilt, unearthed serious problems with research on a protein subtype of amyloid beta that has been a cornerstone of research and spending on Alzheimer’s for over a decade.

Schrag found that images accompanying highly cited Alzheimer’s studies touting major breakthroughs for the field were very plausibly altered. Using the online platform PubPeer, where scientists flag mistakes in research, Schrag stumbled upon comments on articles led by Sylvain Lesné, PhD, of the University of Minnesota.

One of the papers, published in Nature, has been cited 2,300 times, and related NIH funding for related oligomer and Alzheimer’s research grew to $287 million. Lesné and the lab where he worked won accolades: awards, grants, and prominence. “You can cheat to get a paper. You can cheat to get a degree. You can cheat to get a grant. You can’t cheat to cure a disease,” Schrag told Science Magazine. “Biology doesn’t care.”

(See link for article)

_____________________

SUMMARY:

  • Nature has learned that formal investigations finding multiple instances of research misconduct including data falsification and plagiarism have been made against superstar cancer researcher Carlo Croce, MD and scientists under him.
  • So far nobody is admitting fault, and in fact Croce is suing the university despite the committee saying he was a poor mentor and the lab lacked oversight.  Further, the university instructed Croce and his team to retract or correct more than a dozen papers but only one has been retracted and two corrected.
  • Biotronick, a medical device manufacturer, paid and rewarded docs to use their implantable heart devices and violated the False Claims Act when they submitted reimbursement claims for the related procedures from Medicare and Medicaid, according to the DOJ.  The company paid for training that never occurred, as well as holiday parties, winery tours, lavish meals, international business class airfare and honoraria with no legitimate business purpose.

Hopefully, it is becoming clearer by the day that science has been completely hijacked.  It was recently discovered that $350 Million in secret payments have been given to Fauci, Collins, and other NIH scientists.  Corruption in public health has been exposed beautifully thanks to COVID, but is certainly not new.  Lymeland has been riddled with corruption for over 40 years. There is an urgent need to break the public health monopoly which is literally getting away with murder.

The CARES Act, provides hospitals with bonus incentive payments for all things related to COVID-19 (testing, diagnosing, admitting to hospital, use of remdesivir and ventilators, reporting COVID-19 deaths, and vaccinations) and waivers of customary and long-standing patient rights by the Centers for Medicare and Medicaid Services (CMS) are the reasons patients are virtual prisoners in the hospital.  They have no choice, no say, and are barbarically isolated from family members. They are only allowed “FDA approved” COVID treatments which are dangerous, ineffective, and expensive.

Time for a CDC/NIAID FDA/ walkaway movement.

For more:

Category:

Activism, research

Comments Off on Doctored Images, Fake Data, & Plagiarism: Scandals Rock Alzheimer’s & Cancer Research. Research Director Falsifying Vaccine Data Retains Post

Disulfiram for Lyme Update #2

https://www.treatlyme.net/guide/antabuse-disulfiram-chronic-lyme-disease-treatment  Video and Article Here

Updated: 5/9/2022

About Disulfiram and Lyme Disease

By Dr. Marty Ross

For 30 percent of people with chronic Lyme disease, disulfiram is a game changer. This is a medicine historically used to treat people with alcoholism. Ground-breaking research from Dr. Rajadas’ Stanford University lab in 2016 showed disulfiram kills persister and growing forms of Lyme germs. Based on Rajada’s research, disulfiram is being repurposed as a Lyme antibiotic.

In alcoholism, disulfiram prevents the breakdown of a toxic alcohol by-product called acetaldehyde. As acetaldehyde builds up, it makes a person sick with severe abdominal pains and even headaches. In alcoholism, a person takes this medicine daily to prevent them from drinking out of fear it will cause severe illness if they drink alcohol.

In Lyme disease, we do not know the mechanism of how disulfiram works. But we do know in the laboratory that it kills Lyme persisters and is moderately effective at treating growing Lyme too. We also theorize that it breaks up biofilm slime layers that protect the germs.

(See link for article and 7 Min video)

____________________

**Comment**

Please read Dr. Ross’s article in full as well as watch the video.  He gives dosages as well as supportive supplements.

SUMMARY of effectiveness:

Dr. Liegner’s review of his patient’s charts shows:

  • 92.5 percent of people have varying degrees of improvements
  • 36.4 percent – enduring remission (clinically well for 6 months without anti-infectives)
  • 49.3 percent – fatigue as a side effect
  • 31.3 percent – psychiatric problems like anxiety, depression, hallucinations
  • 14.9 percent – neuropathy
  • 14.9 percent – liver enzyme elevation
  • 50 percent – unable to reach the target dose due to side effects (see dosing section below)

Dr. Ross states: Even if a person cannot reach the target dose, in my experience many get benefit by staying at a dose they can tolerate for at least 4 months.

Dr. Ross also states that Disulfiram doesn’t work for Bartonella but may help Babesia.

Please also see:

If you are a single person, please educate yourself about the psychiatric issues.  Never take this drug without a plan in place to have people checking in on you daily.  Take it from me – you can go mad as a hatter and be completely oblivious to your madness.  Been there, done that.  Neuropathy can also be a real side effect problem.

I’m still glad I tried it!

Category:

Babesia, Lyme, Treatment

Comments Off on Disulfiram for Lyme Update #2

Could There Be Subclinical Cardiac Involvement in Early Lyme Disease in Children?

https://danielcameronmd.com/could-there-be-subclinical-cardiac-involvement-in-early-lyme-disease-in-children/

Could there be subclinical cardiac involvement in early Lyme disease in children?

cardiac-lyme-disease-children
Cardiac involvement has been observed during the early disseminated stage Lyme disease. Could there be subclinical cardiac involvement in early Lyme disease in children?
By

In an earlier study by Woolf and colleagues, nearly 1 in 5 children (19.6%) children with an erythema migrans (EM) rash or a positive two-tier Lyme serology had EKG evidence of carditis. Twenty-four of the children had atrioventricular (11.2%). Their study did not report troponin levels.¹

High-sensitivity cardiac troponin assays have been used to identify patients at high risk of cardiovascular and non-cardiovascular events.² The authors identified pneumonia, an infective exacerbation of chronic obstructive pulmonary disease, and sepsis as causes of noncardiovascular events.

Lewandrowski and colleagues looked at high-sensitivity troponin T in 41 individuals with early Lyme disease.³ All individuals presenting in the summer of 2015 met the Centers for Disease Control and Prevention (CDC) surveillance case definition of EM.

“One patient had a value greater than the cutoff used for acute myocardial infarction,” wrote the authors.³ Another five patients had high-sensitivity troponin T values significantly above the expected values for their sex (p<0.0001).

There are many possible explanations for increased high-sensitivity troponin T values in different patients in the absence of acute cardiac damage. “cTn (cardiac troponin assay) is commonly elevated in acute non-ACS conditions, as well as in chronic diseases,” wrote Park and colleagues. They added, “It is unclear why these elevations occur; yet they cannot be ignored as cTn levels in chronically unwell patients are directly correlated to prognosis.”4

“Our results raise the possibility that subclinical cardiac involvement may be more common in ELD than previously recognized,” wrote the authors. They added, further studies will be necessary to elucidate the significance of this finding.”

Lyme carditis

Lyme carditis is uncommon. Nevertheless, Kannangara and colleagues summarized the growing list of cardiac problems in Lyme disease, as described in the medical literature:

  • First-degree heart block
  • Wenckebach phenomenon (Mobitz type I)
  • Mobitz type II
  • Complete Heart block / High degree AV block
  • Bundle branch block
  • Sinus arrest / Sinus pauses
  • Supraventricular tachycardia
  • Atrial fibrillation
  • Junctional tachycardia
  • Fascicular tachycardia
  • Ventricular tachycardia
  • Ventricular flutter
  • Bradycardia
  • Narrow QRS escape rhythm
  • Prolonged QT
  • ST depression / T inversion
  • ST elevation
  • Asystole
  • History of Wolf Parkinson White Syndrome. In a case of sudden death due to LC (Lyme Carditis).
Related Articles:

Podcast: Boy with severe cardiac Lyme disease
12-year-old boy suffers cardiac arrest due to Lyme disease
Growing list of cardiac problems in Lyme disease

References:
  1. Woolf PK, Lorsung EM, Edwards KS, et al. Electrocardiographic findings in children with Lyme disease. Pediatr Emerg Care. Dec 1991;7(6):334-6. doi:10.1097/00006565-199112000-00003
  2. Chapman AR, Adamson PD, Shah ASV, et al. High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction. Circulation. Jan 21 2020;141(3):161-171. doi:10.1161/CIRCULATIONAHA.119.042960
  3. Lewandrowski EL, Lewandrowski K. Measurement of High Sensitivity Troponin T in Patients with Early Stage Lyme Disease: Preliminary Evidence for Possible Subclinical Cardiac Involvement. Ann Clin Lab Sci. Mar 2022;52(2):179-184.
  4. Park KC, Gaze DC, Collinson PO, Marber MS. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res. Dec 1 2017;113(14):1708-1718. doi:10.1093/cvr/cvx183

________________

**Comment**

Again, something can not be labeled as “rare” if nobody’s looking for it.  And this article just presented the fact that many are walking around with sub-clinical cases.  I believe this is far more common than many believe.  Patients will get tests but they all return “normal” yet they have flagrant symptoms.

The other fly in the ointment are the COVID shots, now fraudulently authorized for children who don’t need them.  Many are having heart issues with high troponin levels.  Also, the CDC only reports on two types: pericarditis and myocarditis.  There are many other types of heart issues. Now, it will be even harder to diagnose these kids.

Category:

Lyme, research

Comments Off on Could There Be Subclinical Cardiac Involvement in Early Lyme Disease in Children?

COVID Shot Testimonies & CDC Can’t Hide This Anymore: Leaked Emails. Is This Why Fauci’s Retiring?

August 3, 2022

https://odysee.com/@Commentator:e4/video_2022-03-16_13-10-03:9?src=embed

Approx. 1 hour 40 min

MRNA ‘VACCINE’ GENOCIDE 2021-2022: TESTIMONIES FROM THE VICTIMS AND MEDICAL STAFF

Hear the voices you will not hear on mainstream media.

http://  Approx. 21 Min

Aug. 1, 2022

CDC Can’t Hide This Anymore – Leaked Emails

The CDC is refusing to hand over data about vaccine trials and possible adverse affects, despite a request for this information. Also, new emails show that the CDC worked in lockstep with social media companies to help shut down any conversation around vaccines that they did not like.  It’s clear Big Tech has colluded with the federal government to censor, silence, and suppress free speech.

Internal communications obtained and shared by America First Legal (AFL) show that the CDC had consistent contact with officials from corporate social media companies to address the spread of “misinformation.” AFL received the documents after filing a Freedom Of Information Act (FOIA) request with the CDC and a lawsuit to expedite the process.

The documents show personal communications between Carol Crawford, the Digital Media Branch Chief for the CDC, and representatives of Google, Facebook, and Twitter.

The emails show that Facebook gave the CDC and the Department of Health and Human Services (HHS) over $15 million in free advertising on the platform, described as a “non-monetary gift.”  Source

“CDC and social media worked hand-in-glove propagandizing the false narrative:

  1. Masks work
  2. They are “safe and effective”  (The COVID injections)
  3. They reduce the risk of hospitalization and death (the injections)
  4. They “protect others” i.e. reduce spread (the injections)

Dr. Peter McDullough

________________

July 18 (Reuters) – Dr. Anthony Fauci, the chief medical adviser to the White House, confirmed he will retire by the end of President Joe Biden’s first term, but it could come much earlier than that, the infectious disease expert told Reuters in an interview on Monday.

For more on Fauci:

For more on COVID injections:

Category:

Activism, vaccines, Viruses

Comments Off on COVID Shot Testimonies & CDC Can’t Hide This Anymore: Leaked Emails. Is This Why Fauci’s Retiring?

Paxlovid Rebound Strikes Again

http://

The Kim Iversen Show

Aug. 1, 2022

Biden Pushes More Pills and Shots Despite Rebounds

There’s no data on Paxlovid on those who have had COVID shots.  Fauci also suffered a rebound case, which was worse than his first go around.

________________

https://www.medpagetoday.com/opinion/second-opinions

What’s Really Driving COVID ‘Rebound’ After Paxlovid?

— There’s only one way to find out

by Daniel A. Sweeney, MD, Cameron R. Wolfe, MBBS, MPH, and Andre C. Kalil, MD, MPH August 2, 2022

A photo of the packaging and blisterpack of Paxlovid.

In the early days of the pandemic there was an understandable rush to define and optimally treat COVID-19. Anecdotal evidence and the opinions of eminent scientists and non-scientists overwhelmed social and mainstream media platforms only to eventually be overruled by the results of careful, scientific analyses and well-designed clinical trials. Now, more than 2 years into the pandemic, we must return to the standard of careful and thorough analyses for all interventions and treatments.

The debate about “COVID-19 rebound” after nirmatrelvir/ritonavir (Paxlovid) treatment is one of these timely areas warranting further investigation. Continuing down the current path of uncertainty has consequences for how and by whom this antiviral should be used. However, by applying lessons learned from the early days of the pandemic — including acknowledging the importance of randomized controlled trials (RCTs) — we can avoid repeating the same mistakes. To do this, it is necessary to start by defining the question, identifying current knowledge gaps, and only then can one propose scientific solutions to bring a rapid resolution to the COVID-19 rebound controversy.  (See link for article)

_________________

**Comment**

Aside from the ever-mounting cases of Paxlovid rebound, Drs. Marik and Kory have been shouting from the rooftops about the dangers of taking Paxlovid. Said Dr. Kory in another recent Op-Ed:

“The problems with Paxlovid are no secret. FDA granted Pfizer emergency use authorization for the drug after a single trial with questionable results. The medicine has many contraindications, meaning it can’t be taken by someone who simultaneously would be taking certain anti-depressants, anti-seizure, anti-psychotic, cholesterol, or blood pressure medications. Furthermore, many Americans cannot take Paxlovid, given that nearly half of adults have cardiovascular disease.

“Consider the Food and Drug Administration’s recent decision allowing pharmacists to play doctor and prescribe Pfizer’s anti-viral treatment Paxlovid. No pharmacist could ever safely dispense a novel medicine with an unprecedented amount of drug interactions without in-depth knowledge of the severity of the patient’s medical problems or the critical necessity of each of their other medicines.

“Biden’s policy of a toxic jab in every arm and a pricey pill in every mouth needs an overhaul.”

Early treatment works. The FLCCC Protocols work. And hundreds of thousands are alive today to prove it.

But rather than take a cheap, effective, safe drug (ivermectin among others) – politicians continue to push expensive injections and medicines that not only don’t work, but are dangerous.

Category:

Treatment, Viruses

Comments Off on Paxlovid Rebound Strikes Again